<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32162544</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3-4</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Characterization of the amyotrophic lateral sclerosis-linked P56S mutation of the <i>VAPB</i> gene in Southern Brazil.</ArticleTitle><Pagination><StartPage>286</StartPage><EndPage>290</EndPage><MedlinePgn>286-290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2020.1738495</ELocationID><Abstract><AbstractText><i>Objective</i>: Amyotrophic lateral sclerosis (ALS) is a rare worldwide heterogeneous neurodegenerative disease with sporadic and familial (FALS) forms. A rare autosomal dominant subtype of FALS was identified in a Brazilian family, classified as ALS type 8 (ALS8) linked to the <i>VAPB</i> gene. The aim of our study was to analyze a series of ALS8 patients from unrelated families in order to further characterize the disease. <i>Methods:</i> We reviewed only patients with probable or definite ALS according to the Awaji criteria being managed at a single center between 2004 and 2018 and with DNA samples available for genetic analysis. A retrospective analysis of clinical, laboratory, and electrophysiological features was performed, relevant data were recorded and DNA was analyzed to detect <i>VAPB</i> gene mutation. <i>Results:</i> Thirty-one ALS patients were eligible for genetic screening for ALS8 and the mutation was detected in five patients from unrelated families. The mean age of onset was 45&#x2009;&#xb1;&#x2009;5.3 years for the ALS8 group and 47.6&#x2009;&#xb1;&#x2009;13.1 years for the non-ALS8 group and the time between symptom onset and last follow-up was longer for ALS8 patients. Three patients in the ALS8 group had tremor (60%), four had pain in affected limb (80%) and all had cramps and abdominal protrusion. <i>Conclusions:</i> This study presents the largest series of ALS8 patients in southern Brazil. Our findings demonstrate several clinical features that may be characteristic of ALS8 and confirm that clinicians should suspect ALS8 when the clinical manifestations include cramps, abdominal protrusion, pain, and tremor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trilico</LastName><ForeName>Matheus Luis Castelan</ForeName><Initials>MLC</Initials><Identifier Source="ORCID">0000-0003-4417-1277</Identifier><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzoni</LastName><ForeName>Paulo Jos&#xe9;</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kay</LastName><ForeName>Cl&#xe1;udia Suemi Kamoi</ForeName><Initials>CSK</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducci</LastName><ForeName>Renata Dal Pra</ForeName><Initials>RDP</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fustes</LastName><ForeName>Otto Jesus Hernandez</ForeName><Initials>OJH</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werneck</LastName><ForeName>Lineu Cesar</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scola</LastName><ForeName>Rosana Herminia</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Service of Neuromuscular Disorders, Division of Neurology, Department of Internal Medicine, Hospital de Cl&#xed;nicas, Universidade Federal do Paran&#xe1; (UFPR), Curitiba, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496748">VAPB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">VAPB</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32162544</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1738495</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>